Logotype for Pro-Dex Inc

Pro-Dex (PDEX) Q2 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Pro-Dex Inc

Q2 2026 earnings summary

29 Jan, 2026

Executive summary

  • Net sales for the quarter ended December 31, 2025, increased 11% year-over-year to $18.7 million, with six-month sales up 17% to $37.2 million, driven by strong growth in orthopedic and CMF device sales and next-generation handpiece shipments.

  • Net income for the quarter was $2.2 million, up 7% year-over-year, and $6.9 million for the six months, a 52% increase, reflecting higher sales and a significant realized gain on investment.

  • Gross margin for the quarter was 31%, up 1 percentage point year-over-year, while the six-month margin was 30%, down 2 points due to increased inventory and warranty charges and less favorable product mix.

  • Operating income rose to $3.3 million for the quarter and $6.4 million for the six months, reflecting improved sales and cost control.

Financial highlights

  • Orthopedic device sales rose 27% for the quarter and 43% for the six months, driven by the launch of a next-generation handpiece for the largest customer.

  • CMF device sales increased 69% for the quarter and 47% for the six months, while thoracic sales declined 83% and 67%, respectively.

  • Repair revenue declined 35% for the quarter and 30% for the six months due to fewer repairs of legacy products.

  • Realized a $6.8 million gain from the sale of Monogram Technologies shares following its acquisition by Zimmer Biomet, with a $3.2 million reversal of unrealized gains.

  • Cash and cash equivalents increased to $8.0 million at December 31, 2025, from $419,000 at June 30, 2025.

Outlook and guidance

  • Backlog at December 31, 2025, was $37.4 million, with $32.5 million scheduled for delivery in fiscal 2026.

  • Management expects continued growth in orthopedic sales for the remainder of the fiscal year and is pursuing the acquisition of a key supplier to meet demand.

  • A three-year contract extension with the largest customer is expected to support continued growth.

  • The company is focused on expanding manufacturing capacity and launching new products, including the Helios driver for CMF applications.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more